SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-18-025415
Filing Date
2018-05-04
Accepted
2018-05-04 16:30:34
Documents
2
Group Members
CORA MADSENFLORIAN SCHONHARTINGNB PUBLIC EQUITY KOMPLEMENTAR APS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv493010_sc13g.htm SC 13G 63283
2 EXHIBIT 99.1 tv493010_ex99-1.htm EX-99.1 11869
  Complete submission text file 0001144204-18-025415.txt   76696
Mailing Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011
Business Address 11804 NORTH CREEK PARKWAY SOUTH BOTHELL WA 98011 425-205-2900
ALDER BIOPHARMACEUTICALS INC (Subject) CIK: 0001423824 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88142 | Film No.: 18808353
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address OESTERGADE 24A,1 DK-1100 COPENHAGEN G7 -----
Business Address OESTERGADE 24A,1 DK-1100 COPENHAGEN G7 ----- 45 70 20 12 63
NB Public Equity K/S (Filed by) CIK: 0001451330 (see all company filings)

IRS No.: 000000000
Type: SC 13G